|
A.V. Fateeva, E.V. Eliseeva, V.I. Apanasevich, A.A. Zaemskaya
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice
|
№7 / 2024
|
|
Yu.G. Belotserkovskaya, A.G. Romanovskikh, I.P. Smirnov
Problems of managing patients with COPD in the post-pandemic waves of COVID-19
|
№9/10 / 2023
|
|
G.A. Ignatenko, G.G. Taradin, L.V. Kononenko
Cardiac myosin inhibitors in the treatment of hypertrophic cardiomyopathy (literature review)
|
№9/10 / 2023
|
|
E.V. Filippova, O.V. Kolomiets, M.A. Puolokaynen, E.E. Malygin
Modern approaches to the treatment of patients with alcohol withdrawal syndrome
|
№13 / 2022
|
|
A.A. Gavrilova, R.A. Bontsevich
Analysis and optimization of approaches to the treatment of community-acquired pneumonia in real clinical practice
|
№5 / 2022
|
|
R.V. Akhapkin1, 2, N.V. Mironova2
MODERN VIEW ON THE DIAGNOSTICS AND THERAPY OF POSTSTROKE DEPRESSIONS
|
№9 / 2017
|
|
V.A. Revyakina
ALLERGIC RHINITIS IN CHILDREN. CURRENT REALITIES
|
№1 / 2017
|
|
N.N. Zavadenko
ANXIETY DISORDERS IN CHILDREN AND ADOLESCENTS
|
№s4-16 / 2016
|
|
M.A. Kurapov (1), Ya.V. Vlasov (2)
PHARMACOTHERAPY OF MULTIPLE SCLEROSIS: TREATMENT OF EXACERBATIONS, IMMUNOMODULATORY THERAPY
|
№s4-16 / 2016
|
|
A. V. Starodubova, O. A. Kislyak
OBESITY AS A RISK FACTOR FOR CARDIOVASCULAR DISEASES. LITERATURE REVIEW
|
№17 / 2015
|
|
K.S.Danilina (1), D.A. Sychev (1), O.V. Golovina (1), E.S.Ilina (1), S.V.Gorbotenkova (2)
FREQUENCY OF PRESCRIPTION OF POTENTIALLY NOT RECOMMENDED DRUGS (ACCORDING «STOPP START» CRITERIA) FOR ELDERLY PATIENTS WHO ARE TREATED IN THE THERAPEUTIC DEPARTMENTS OF HOSPITAL: RESULTS OF PHARMACOEPIDEMIOLOGICAL STUDY
|
№13 / 2015
|
|
A.V. Ushkalova (1), E.A. Ushkalova (2)
CURRENT RECOMMENDATIONS FOR PHARMACOTHERAPY OF ACUTE EPISODES OF BIPOLAR DEPRESSION
|
№s3-15 / 2015
|
Русский
